The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Chloroquine and its analogs: A new promise of an old drug for effective and safe cancer therapies
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Rosato, R. R., Maggio, S. C., Almenara, J. A., Payne, S. G., Atadja, P. W., Spiegel, S., Dent, P., & Grant, S. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.017145 · Cited by 91
RetractedApoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,725
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
Apoptosis in the Pathogenesis and Treatment of Disease
Thompson, C. B. (1995) · Science · doi:10.1126/science.7878464 · Cited by 6,524
The price of innovation: new estimates of drug development costs
DiMasi, J. A., Hansen, R. W., & Grabowski, H. G. (2003) · Journal of Health Economics · doi:10.1016/s0167-6296(02)00126-1 · Cited by 4,265
Molecular characterization of mitochondrial apoptosis-inducing factor
Susin, S. A., Lorenzo, H. K., Zamzami, N., Marzo, I., Snow, B. E., Brothers, G. M., Mangion, J., Jacotot, E., Costantini, P., Loeffler, M., et al. (1999) · Nature · doi:10.1038/17135 · Cited by 4,060
Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death
Wei, M. C., Zong, W.-X., Cheng, E. H.-Y., Lindsten, T., Panoutsakopoulou, V., Ross, A. J., Roth, K. A., MacGregor, G. R., Thompson, C. B., & Korsmeyer, S. J. (2001) · Science · doi:10.1126/science.1059108 · Cited by 3,988
(1989) · PubMed · Cited by 3,343
Apoptosis, oncosis, and necrosis. An overview of cell death.
Majno, G., & Joris, I. (1995) · PubMed · Cited by 3,306
Mechanisms of phagocytosis in macrophages
Aderem, A., & Underhill, D. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.593 · Cited by 2,854
Proliferation, cell cycle and apoptosis in cancer
Evan, G. I., & Vousden, K. H. (2001) · Nature · doi:10.1038/35077213 · Cited by 2,724
Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene
Qu, X., Yu, J., Bhagat, G., Furuya, N., Hibshoosh, H., Troxel, A., Rosen, J., Eskelinen, E.-L., Mizushima, N., Ohsumi, Y., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci20039 · Cited by 2,311
Autophagy in cell death: an innocent convict?
Levine, B. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26390 · Cited by 1,676
The role of autophagy in cancer development and response to therapy
Kondo, Y., Kanzawa, T., Sawaya, R., & Kondo, S. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1692 · Cited by 1,654
Mitochondrial control of nuclear apoptosis.
Zamzami, N., Susin, S. A., Marchetti, P., Hirsch, T., Gómez-Monterrey, I., Castedo, M., & Kroemer, G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1533 · Cited by 1,361
Lowe, S. W., Cepero, E., & Evan, G. (2004) · Nature · doi:10.1038/nature03098 · Cited by 1,309
Lysosomes and autophagy in cell death control
Kroemer, G., & Jäättelä, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1738 · Cited by 1,285
Effects of chloroquine on viral infections: an old drug against today's diseases
Savarino, A., Boelaert, J. R., Cassone, A., Majori, G., & Cauda, R. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00806-5 · Cited by 1,268
Regulation of an ATG7 - beclin 1 Program of Autophagic Cell Death by Caspase-8
Yu, L., Alva, A., Su, H., Dutt, P., Freundt, E., Welsh, S., Baehrecke, E. H., & Lenardo, M. J. (2004) · Science · doi:10.1126/science.1096645 · Cited by 1,220
Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma
Amaravadi, R. K., Yu, D., Lum, J. J., Bui, T., Christophorou, M. A., Evan, G. I., Thomas-Tikhonenko, A., & Thompson, C. B. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28833 · Cited by 1,137
Chong, C. R., & Sullivan, D. J. (2007) · Nature · doi:10.1038/448645a · Cited by 983
Apoptotic cell death induced by c-myc is inhibited by bcl-2
Bissonnette, R. P., Echeverri, F., Mahboubi, A., & Green, D. R. (1992) · Nature · doi:10.1038/359552a0 · Cited by 957
Salmonella mutagenicity test results for 250 chemicals
Haworth, S., Lawlor, T., Mortelmans, K., Speck, W., & Zeiger, E. (1983) · Environmental Mutagenesis · doi:10.1002/em.2860050703 · Cited by 898
Endogenous MHC Class II Processing of a Viral Nuclear Antigen After Autophagy
Paludan, C., Schmid, D., Landthaler, M., Vockerodt, M., Kube, D., Tuschl, T., & Münz, C. (2005) · Science · doi:10.1126/science.1104904 · Cited by 860 · cited 2×
“Some studies also suggested that CQ increases cell death by blocking fusion of autophagosomeswith lysosomes (Paludan et al., 2005; Shacka et al., 2006), while others postulated that accumulation of CQ in the lysosomes inhibits the acid-dependent degradation of autophagosomes (Amaravadi et al.”
BackgroundAutophagy: in sickness and in health
Maria Cuervo, A. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2003.12.002 · Cited by 815
Cooperative interaction between c-myc and bcl-2 proto-oncogenes
Fanidi, A., Harrington, E. A., & Evan, G. I. (1992) · Nature · doi:10.1038/359554a0 · Cited by 759
Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages.
Poole, B., & Ohkuma, S. (1981) · The Journal of cell biology · doi:10.1083/jcb.90.3.665 · Cited by 751
ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles
The Breast Cancer Susceptibility Collaboration (UK), Renwick, A., Thompson, D., Seal, S., Kelly, P., Chagtai, T., Ahmed, M., North, B., Jayatilake, H., Barfoot, R., et al. (2006) · Nature Genetics · doi:10.1038/ng1837 · Cited by 743
Apoptosis, autophagy, and more
Lockshin, R. A., & Zakeri, Z. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.04.011 · Cited by 700
New insights into the antiviral effects of chloroquine
Savarino, A., Di Trani, L., Donatelli, I., Cauda, R., & Cassone, A. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70361-9 · Cited by 570
Autophagy and aging: keeping that old broom working
Cuervo, A. M. (2008) · Trends in Genetics · doi:10.1016/j.tig.2008.10.002 · Cited by 527
Laske, D. W., Youle, R. J., & Oldfield, E. H. (1997) · Nature Medicine · doi:10.1038/nm1297-1362 · Cited by 525
Oncogenic PI3K and its role in cancer
Samuels, Y., & Ericson, K. (2006) · Current Opinion in Oncology · doi:10.1097/01.cco.0000198021.99347.b9 · Cited by 521
On the molecular mechanism of chloroquine's antimalarial action.
Sullivan, D. J., Gluzman, I. Y., Russell, D. G., & Goldberg, D. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11865 · Cited by 508
Sotelo, J., Briceño, E., & López-González, M. A. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-5-200603070-00008 · Cited by 505
Tannock, I. F., Lee, C. M., Tunggal, J. K., Cowan, D., & Egorin, M. J. (2002) · PubMed · Cited by 505
Fader, C. M., Sánchez, D., Furlán, M., & Colombo, M. I. (2008) · Traffic · doi:10.1111/j.1600-0854.2007.00677.x · Cited by 470
The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells
Lu, Z., Luo, R. Z., Lu, Y., Zhang, X., Yu, Q., Khare, S., Kondo, S., Kondo, Y., Yu, Y., Mills, G. B., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35512 · Cited by 466
(2003) · PubMed · Cited by 465
Wiesner, J., Ortmann, R., Jomaa, H., & Schlitzer, M. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200200569 · Cited by 428
Zamora, J. M., Pearce, H. L., & Beck, W. T. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13330-0 · Cited by 410
O'Connor, O. A., Heaney, M. L., Schwartz, L., Richardson, S., Willim, R., MacGregor-Cortelli, B., Curly, T., Moskowitz, C., Portlock, C., Horwitz, S., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.9679 · Cited by 404
Malarial haemozoin/β-haematin supports haem polymerization in the absence of protein
Dorn, A., Stoffel, R., Matile, H., Bubendorf, A., & Ridley, R. G. (1995) · Nature · doi:10.1038/374269a0 · Cited by 389
Boya, P., Gonzalez-Polo, R.-A., Poncet, D., Andreau, K., Vieira, H. L., Roumier, T., Perfettini, J.-L., & Kroemer, G. (2003) · Oncogene · doi:10.1038/sj.onc.1206622 · Cited by 385
Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient
Mayer, L. D., Bally, M. B., & Cullis, P. R. (1986) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(86)90105-7 · Cited by 379
Münster, P. N., Troso-Sandoval, T. A., Rosen, N. X., Rifkind, R. A., Marks, P. A., & Richon, V. M. (2001) · PubMed · Cited by 368
Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents
Degtyarev, M., De Mazière, A., Orr, C., Lin, J., Lee, B. B., Tien, J. Y., Prior, W. W., van Dijk, S., Wu, H., Gray, D. C., et al. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200801099 · Cited by 366
Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies
Brown, J. M. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(00)01677-4 · Cited by 350
Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis
Pharoah, P. D. P., Day, N. E., & Caldas, C. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690628 · Cited by 308
Maclean, K. H., Dorsey, F. C., Cleveland, J. L., & Kastan, M. B. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33700 · Cited by 272
Schindler, M., Grabski, S., Hoff, E., & Simon, S. M. (1996) · Biochemistry · doi:10.1021/bi952234e · Cited by 269
New Paradigms in Anticancer Therapy: Targeting Multiple Signaling Pathways With Kinase Inhibitors
FAIVRE, S., DJELLOUL, S., & RAYMOND, E. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.04.005 · Cited by 264
Walenta, S., Schroeder, T., & Mueller-Klieser, W. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043364711 · Cited by 248
Dai, Y., Rahmani, M., Dent, P., & Grant, S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.13.5429-5444.2005 · Cited by 245
Schlitzer, M. (2007) · ChemMedChem · doi:10.1002/cmdc.200600240 · Cited by 244
Dalpke, A. H., Opper, S., Zimmermann, S., & Heeg, K. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7082 · Cited by 241
Newell, K., Franchi, A., Pouysségur, J., & Tannock, I. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.3.1127 · Cited by 197
Prognostic significance of apoptosis regulators in breast cancer.
Krajewski, S., Krajewska, M., Turner, B. C., Pratt, C., Howard, B., Zapata, J. M., Frenkel, V, Robertson, S., Ionov, Y., Yamamoto, H., et al. (1999) · Endocrine-related cancer · doi:10.1677/erc.0.0060029 · Cited by 186
Therapy of glioblastoma multiforme improved by the antimutagenic chloroquine
Briceño, E., Reyes, S., & Sotelo, J. (2003) · Neurosurgical Focus · doi:10.3171/foc.2003.14.2.4 · Cited by 185
Regulated exocytosis: a novel, widely expressed system
Borgonovo, B., Cocucci, E., Racchetti, G., Podini, P., Bachi, A., & Meldolesi, J. (2002) · Nature Cell Biology · doi:10.1038/ncb888 · Cited by 177
Chloroquine inhibits cell growth and induces cell death in A549 lung cancer cells
Fan, C., Wang, W., Zhao, B., Zhang, S., & Miao, J. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.12.035 · Cited by 176
Mutations in Diphtheria Toxin Separate Binding from Entry and Amplify Immunotoxin Selectivity
Greenfield, L., Johnson, V. G., & Youle, R. J. (1987) · Science · doi:10.1126/science.3498987 · Cited by 173
Stambolic, V., & Woodgett, J. R. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.07.001 · Cited by 172
Adjuvant therapy in colon cancer—what, when and how?
Chau, I., & Cunningham, D. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl029 · Cited by 167
Bafilomycin A1 Inhibits Chloroquine-Induced Death of Cerebellar Granule Neurons
Shacka, J. J., Klocke, B. J., Shibata, M., Uchiyama, Y., Datta, G., Schmidt, R. E., & Roth, K. A. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.018408 · Cited by 163
Antimalarial Chemotherapy. Mechanisms of Action, Resistance and New Directions in Drug Discovery
(2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg183 · Cited by 157
Woodfork, K. A., Wonderlin, W. F., Peterson, V. A., & Strobl, J. S. (1995) · Journal of Cellular Physiology · doi:10.1002/jcp.1041620202 · Cited by 155
Ovarian cancer: pathology, biology, and disease models
Daniel, G. R. (2009) · Frontiers in bioscience · doi:10.2741/3364 · Cited by 154
Cheng, J. (2008) · Current Cancer Drug Targets · doi:10.2174/156800908783497104 · Cited by 139
Law, P., Hom, D. S., & Loh, H. H. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43014-6 · Cited by 138
Reagan‐Shaw, S., & Ahmad, N. (2005) · The FASEB Journal · doi:10.1096/fj.04-2910fje · Cited by 138
Vesicular Anthracycline Accumulation in Doxorubicin-Selected U-937 Cells: Participation of Lysosomes
Hurwitz, S. J., Terashima, M., Mizunuma, N., & Slapak, C. A. (1997) · Blood · doi:10.1182/blood.v89.10.3745 · Cited by 137
p53 downstream targets and chemosensitivity
Sax, J. K., & El‐Deiry, W. S. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401227 · Cited by 133
Conflicts of interest: the genesis of synthetic antimalarial agents in peace and war
Greenwood, D. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/36.5.857 · Cited by 131
Controlled trial with chloroquine diphosphate in systemic lupus erythematosus
Meinão, I., Sato, E. I., Andrade, L. E. C., Ferraz, M., & Atra, E. (1996) · Lupus · doi:10.1177/096120339600500313 · Cited by 131
Hormone-induced refractoriness to mammary carcinogenesis in Wistar- Furth rats
Sivaraman, L., Stephens, L. C., Markaverich, B. M., Clark, J. A., Krnacik, S., Conneely, O. M., O'Malley, B. W., & Medina, D. (1998) · Carcinogenesis · doi:10.1093/carcin/19.9.1573 · Cited by 131
p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis
Sivaraman, L., Conneely, O. M., Medina, D., & O’Malley, B. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221459098 · Cited by 130
Weber, S. M., & Levitz, S. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.3.1534 · Cited by 129
Institutional experience with chloroquine as an adjuvant to the therapy for glioblastoma multiforme
Briceño, E., Calderón, A., & Sotelo, J. (2007) · Surgical Neurology · doi:10.1016/j.surneu.2006.08.080 · Cited by 124
Chloroquine inhibits proinflammatory cytokine release into human whole blood
Karres, I., Kremer, J.-P., Dietl, I., Steckholzer, U., Jochum, M., & Ertel, W. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.4.r1058 · Cited by 124
Advances of AKT Pathway in Human Oncogenesis and as a Target for Anti-Cancer Drug Discovery
Wang, L., Cheng, G. Z., Park, S., Shu, S., He, L., Kong, W. W., Zhang, W., Yuan, Z., & Cheng, J. (2008) · Current Cancer Drug Targets · doi:10.2174/156800908783497159 · Cited by 115
Regulation of intracellular pH in tumor cell lines: influence of microenvironmental conditions.
Boyer, M. J., & Tannock, I. F. (1992) · PubMed · Cited by 112
Mechanism of malarial haem detoxification inhibition by chloroquine
Pandey, A. V., BISHT, H., Babbarwal, V., SRIVASTAVA, J., PANDEY, K. C., & Chauhan, V. S. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3550333 · Cited by 109
Laske, D. W., Ilercil, O., Akbaşak, A., Youle, R. J., & Oldfield, E. H. (1994) · Journal of neurosurgery · doi:10.3171/jns.1994.80.3.0520 · Cited by 108
Zhou, Q. Y., Melkoumian, Z., Lucktong, A., Moniwa, M., Davie, J., & Strobl, J. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003106200 · Cited by 104
Carew, J. S., Nawrocki, S. T., Krupnik, Y. V., Dunner, K., McConkey, D. J., Keating, M. J., & Huang, P. (2005) · Blood · doi:10.1182/blood-2005-05-1923 · Cited by 102
Yang, S., Zhou, Q., & Yang, X. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.03.021 · Cited by 101
Lee, C. M., & Tannock, I. F. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603010 · Cited by 98
The hepatocyte primary culture/DNA repair assay using mouse or hamster hepatocytes
McQueen, C. A., Kreiser, D. M., & Williams, G. M. (1983) · Environmental Mutagenesis · doi:10.1002/em.2860050102 · Cited by 97
Chloroquine levels in blood during chronic treatment of patients with rheumatoid arthritis
Augustijns, P., Geusens, P., & Verbeke, N. (1992) · European Journal of Clinical Pharmacology · doi:10.1007/bf00280130 · Cited by 94
Sehested, M., Jensen, P. B., Sørensen, B. S., Holm, B., Friche, E., & Demant, E. J. F. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90514-w · Cited by 91
Zheng, Y., Zhao, Y., Deng, X., Yang, S., Mao, Y.-Q., Li, Z., Jiang, P., Zhao, X., & Wei, Y. (2009) · Cancer Investigation · doi:10.1080/07357900802427927 · Cited by 88
Hostetler, K. Y., Reasor, M. J., & Yazaki, P. J. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89718-6 · Cited by 86
c-Myc overexpression and endocrine resistance in breast cancer
McNeil, C. M., Sergio, C. M., Anderson, L. R., Inman, C. K., Eggleton, S. A., Murphy, N., Millar, E. K. A., Crea, P., Kench, J. G., Alles, M. C., et al. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.09.028 · Cited by 86
Wang, S., Melkoumian, Z., Woodfork, K. A., Cather, C., Davidson, A. G., Wonderlin, W. F., & Strobl, J. S. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199809)176:3<456::aid-jcp2>3.0.co;2-n · Cited by 84
Titus, E. O. (1989) · Therapeutic Drug Monitoring · doi:10.1097/00007691-198907000-00001 · Cited by 82
Antimalarial Chemotherapy: Mechanisms of Action, Resistance and New Directions in Drug Discovery
Croft, S. L. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)02035-9 · Cited by 82
Phillips, R. M., Loadman, P. M., & Cronin, B. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.355 · Cited by 81
Park, J., Choi, K., Jeong, E.-J., Kwon, D., Benveniste, E. N., & Choi, C. (2004) · Glia · doi:10.1002/glia.20017 · Cited by 80
Hormone-Induced Protection Against Breast Cancer
Sivaraman, L., & Medina, D. (2002) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1015774524076 · Cited by 79
Zhao, H. W., Cai, Y., Santi, S. A., Lafrenie, R. M., & Lee, H. (2005) · Radiation Research · doi:10.1667/rr3436.1 · Cited by 71
Self-citationMechanism of malarial haem detoxification inhibition by chloroquine
Pandey, A. V., BISHT, H., BABBARWAL, V. K., SRIVASTAVA, J., Pandey, K. C., & Chauhan, V. S. (2001) · Biochemical Journal · doi:10.1042/bj3550333 · Cited by 71
Yu, C., Subler, M. A., Rahmani, M., Reese, E., Krystal, G. W., Conrad, D. H., Dent, P., & Grant, S. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.5.454 · Cited by 70
Mishima, Y. M., Terui, Y., Mishima, Y., Taniyama, A., Kuniyoshi, R., Takizawa, T., Kimura, S. H., Ozawa, K., & Hatake, K. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00932.x · Cited by 69
Jiang, P., Zhao, Y., Shi, W., Deng, X., ., G. X., Mao, Y.-Q., Li, Z., Zheng, Y., Yang, S., & Wei, Y.-Q. (2008) · Cellular Physiology and Biochemistry · doi:10.1159/000185488 · Cited by 69
Hu, C., Solomon, V. R., Ulíbarri, G., & Lee, H. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.07.076 · Cited by 67
Self-citationMartirosyan, A., Leonard, S. S., Shi, X., Griffith, B. N., Gannett, P. M., & Strobl, J. S. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.096891 · Cited by 65
Wang, L., Hoque, A. M., Luo, R. Z.-T., Yuan, J., Lü, Z., Nishimoto, A., Liu, J., Şahin, A. A., Lippman, S. M., Bast, R. C., et al. (2003) · PubMed · Cited by 65
Vascular protection by chloroquine during brain tumor therapy with Tf-CRM107.
Hagihara, N., Walbridge, S., Olson, A. W., Oldfield, E. H., & Youle, R. J. (2000) · PubMed · Cited by 64
Loehberg, C. R., Thompson, T., Kastan, M. B., Maclean, K. H., Edwards, D. G., Kittrell, F. S., Medina, D., Conneely, O. M., & O’Malley, B. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-3058 · Cited by 60
Glaumann, H., & Ahlberg, J. (1987) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(87)90018-9 · Cited by 58
Lü, Z., Luo, R. Z.-T., Peng, H., Rosen, D. G., Atkinson, E. N., Warneke, C. L., Huang, M., Nishmoto, A., Liu, J., Liao, W. S. ‐., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1036 · Cited by 56
Chatterjee, T., Muhkopadhyay, A., Khan, K. A., & Giri, A. K. (1998) · Mutagenesis · doi:10.1093/mutage/13.6.619 · Cited by 55
Inaba, M., & Maruyama, E. (1988) · PubMed · Cited by 55
Specific binding of Hoechst 33258 to site 1 thymidylate synthase mRNA
Cho, J., & Rando, R. R. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.10.2158 · Cited by 53
Synthesis and in vitro cytotoxicity evaluation of 4-aminoquinoline derivatives
Zhang, H., Solomon, V. R., Hu, C., Ulíbarri, G., & Lee, H. (2007) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2007.04.007 · Cited by 51
Self-citationFader, C. M., Savina, A., Sánchez, D., & Colombo, M. I. (2005) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2005.07.002 · Cited by 50
Jensen, P. B. (1995) · Lung Cancer · doi:10.1016/0169-5002(95)96441-w · Cited by 47
Cellular Responses to Protein Accumulation Involve Autophagy and Lysosomal Enzyme Activation
Butler, D., Brown, Q. B., Chin, D. J., Batey, L., Karim, S. L., Mutneja, M. S., Karanian, D. A., & Bahr, B. A. (2005) · Rejuvenation Research · doi:10.1089/rej.2005.8.227 · Cited by 46
Genomic structure and promoter characterization of an imprinted tumor suppressor gene ARHI
Luo, R. Z.-T., Peng, H., Xu, F., Bao, J., Pang, Y., Pershad, R., Issa, J. J., Liao, W. S. ‐., Bast, R. C., & Yu, Y. (2001) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(01)00226-3 · Cited by 42
Snyder, R. D. (2000) · Environmental and Molecular Mutagenesis · doi:10.1002/(sici)1098-2280(2000)35:1<13::aid-em3>3.0.co;2-1 · Cited by 38
Effect of cell volume on Acridine Orange fluorescence in hepatocytes
Völkl, H., Friedrich, F., Häussinger, D., & Lang, F. J. W. (1993) · Biochemical Journal · doi:10.1042/bj2950011 · Cited by 35
Trastuzumab and Antiestrogen Therapy: Focus on Mechanisms of Action and Resistance
Ocaña, A., Cruz, J. J., & Pandiella, A. (2006) · American Journal of Clinical Oncology · doi:10.1097/01.coc.0000190274.00570.0a · Cited by 35
Chemoprevention of breast cancer
Thomsen, A., & Kolesar, J. (2008) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp070663 · Cited by 34
New chemotherapeutic agents for breast cancer
Abrams, J. S., Moore, T. D., & Friedman, M. A. (1994) · Cancer · Cited by 32
Quinacrine Enhances Carmustine Therapy of Experimental Rat Glioma
Reyes, S., Herrera, L. A., Ostrosky, P., & Sotelo, J. (2001) · Neurosurgery · doi:10.1227/00006123-200110000-00033 · Cited by 31
On the use of chloroquine for chikungunya
Savarino, A., Cauda, R., & Cassone, A. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70217-7 · Cited by 25
Clinical pharmacology and malaria
Breckenridge, A. M., & Winstanley, P. A. (1997) · Annals of Tropical Medicine and Parasitology · doi:10.1080/00034983.1997.11813196 · Cited by 20
NLCQ-1, a novel hypoxic cytotoxin: potentiation of melphalan, cisDDP and cyclophosphamide in vivo
Papadopoulou, M. V., Ji, M., & Bloomer, W. D. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00333-2 · Cited by 17
Papadopoulou, M. V., Ji, M. H., Ji, X., Bloomer, W. D., & Hollingshead, M. G. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-002-0521-8 · Cited by 16
Beardsley, D. I., Kim, W.-J., & Brown, K. D. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.013888 · Cited by 15
Melkoumian, Z., Martirosyan, A. R., & Strobl, J. S. (2002) · International Journal of Cancer · doi:10.1002/ijc.10648 · Cited by 12
Papadopoulou, M. V., Ji, M., Ji, X., et al. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-002-0491-x · Cited by 12
Modulation of human mammary cell sensitivity to paclitaxel by new quinoline sulfonamides
Chibale, K., Ojima, I., Haupt, H., Geng, X., Pera, P. J., & Bernacki, R. J. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00462-0 · Cited by 9
Chloroquine Treatment Increases Detection of 5-Fluorouracil-Induced Apoptosis In Vivo
Nyati, M. K., Feng, F. Y.-C., Kanade, V. D., & Nayak, R. (2006) · Molecular Imaging · doi:10.2310/7290.2006.00017 · Cited by 4
Cited by
Autophagy and autophagy-related pathways in cancer
Debnath, J., Gammoh, N., & Ryan, K. M. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00585-z · Cited by 1,403
Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
Michaud, M., Martins, I., Sukkurwala, A. Q., Adjemian, S., Ma, Y., Pellegatti, P., Shen, S., Kepp, O., Scoazec, M., Mignot, G., et al. (2011) · Science · doi:10.1126/science.1208347 · Cited by 1,377
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Zhou, Y., Tao, L., Qiu, J., Xu, J., Yang, X., Zhang, Y., Tian, X., Guan, X., Cen, X., & Zhao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01823-2 · Cited by 720
Hydroxychloroquine: From Malaria to Autoimmunity
Ben-Zvi, I., Kivity, S., Langevitz, P., & Shoenfeld, Y. (2012) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-010-8243-x · Cited by 613
Quinoline as a Privileged Scaffold in Cancer Drug Discovery
R. Solomon, V., & Lee, H. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795328382 · Cited by 581
Self-citation
Metadata
- Authors
- Solomon, V. R., & Lee, H.
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2009-12
- Volume
- 625
- Issue
- 1-3
- Pages
- 220-233
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W2147759897
- Cited by
- 516
- References
- 135
- FWCI
- 36.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.